• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在突触中生活的杂乱无章:α-突触核蛋白的多重伴侣在生理和病理中的作用。

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.

机构信息

Division of Pharmacology, Department of molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123, Brescia, Italy.

Department of Clinical Neurosciences, Clifford Allbutt Building, University of Cambridge, Cambridge CB2 0AH, UK.

出版信息

Int J Mol Sci. 2019 Jan 2;20(1):141. doi: 10.3390/ijms20010141.

DOI:10.3390/ijms20010141
PMID:30609739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6337145/
Abstract

Alpha-synuclein (α-syn) is a small protein that, in neurons, localizes predominantly to presynaptic terminals. Due to elevated conformational plasticity, which can be affected by environmental factors, in addition to undergoing disorder-to-order transition upon interaction with different interactants, α-syn is counted among the intrinsically disordered proteins (IDPs) family. As with many other IDPs, α-syn is considered a hub protein. This function is particularly relevant at synaptic sites, where α-syn is abundant and interacts with many partners, such as monoamine transporters, cytoskeletal components, lipid membranes, chaperones and synaptic vesicles (SV)-associated proteins. These protein⁻protein and protein⁻lipid membrane interactions are crucial for synaptic functional homeostasis, and alterations in α-syn can cause disruption of this complex network, and thus a failure of the synaptic machinery. Alterations of the synaptic environment or post-translational modification of α-syn can induce its misfolding, resulting in the formation of oligomers or fibrillary aggregates. These α-syn species are thought to play a pathological role in neurodegenerative disorders with α-syn deposits such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), which are referred to as synucleinopathies. Here, we aim at revising the complex and promiscuous role of α-syn at synaptic terminals in order to decipher whether α-syn molecular interactants may influence its conformational state, contributing to its aggregation, or whether they are just affected by it.

摘要

α-突触核蛋白(α-syn)是一种小蛋白,在神经元中主要定位于突触前末梢。由于构象可塑性增加,这可能受到环境因素的影响,并且在与不同相互作用物相互作用时经历无序到有序的转变,α-syn 被归入无序蛋白(IDPs)家族。与许多其他 IDPs 一样,α-syn 被认为是一种枢纽蛋白。这种功能在突触部位尤为重要,α-syn 在突触部位丰富,并与许多伴侣相互作用,如单胺转运体、细胞骨架成分、脂质膜、伴侣蛋白和突触小泡(SV)相关蛋白。这些蛋白-蛋白和蛋白-脂质膜相互作用对于突触功能的动态平衡至关重要,α-syn 的改变会破坏这个复杂的网络,从而导致突触机制的失败。突触环境的改变或 α-syn 的翻译后修饰会诱导其错误折叠,导致寡聚体或纤维状聚集体的形成。这些α-syn 物种被认为在帕金森病(PD)、路易体痴呆(DLB)和多系统萎缩(MSA)等具有α-syn 沉积的神经退行性疾病中发挥病理作用,这些疾病被称为突触核蛋白病。在这里,我们旨在修正 α-syn 在突触末梢的复杂和混杂作用,以阐明其分子相互作用物是否会影响其构象状态,促进其聚集,或者它们是否只是受其影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/799e318928a7/ijms-20-00141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/61dc3dbe822e/ijms-20-00141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/2482cc5fc06a/ijms-20-00141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/799e318928a7/ijms-20-00141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/61dc3dbe822e/ijms-20-00141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/2482cc5fc06a/ijms-20-00141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c300/6337145/799e318928a7/ijms-20-00141-g003.jpg

相似文献

1
Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.在突触中生活的杂乱无章:α-突触核蛋白的多重伴侣在生理和病理中的作用。
Int J Mol Sci. 2019 Jan 2;20(1):141. doi: 10.3390/ijms20010141.
2
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.α-突触核蛋白纤维在局部和全身给药后会引起不同的突触核蛋白病。
Nature. 2015 Jun 18;522(7556):340-4. doi: 10.1038/nature14547. Epub 2015 Jun 10.
3
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.新型抗体可检测突触核蛋白病中额外的 α-突触核蛋白病理:免疫治疗的潜在发展。
Alzheimers Res Ther. 2020 Nov 30;12(1):159. doi: 10.1186/s13195-020-00727-x.
4
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.在突触核蛋白病中 123I-MIBG 闪烁显像与磷酸化α-突触核蛋白皮肤沉积物的比较。
Parkinsonism Relat Disord. 2020 Dec;81:48-53. doi: 10.1016/j.parkreldis.2020.10.016. Epub 2020 Oct 8.
5
From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies.从发病到进展:突触核蛋白病中α-突触核蛋白的时间谱
Ageing Res Rev. 2025 Feb;104:102640. doi: 10.1016/j.arr.2024.102640. Epub 2024 Dec 10.
6
α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization.α-突触核蛋白原纤维与β-神经连接蛋白结合并损害β-神经连接蛋白介导的突触前组织。
Cells. 2023 Apr 4;12(7):1083. doi: 10.3390/cells12071083.
7
The Synaptic Function of α-Synuclein.α-突触核蛋白的突触功能。
J Parkinsons Dis. 2015;5(4):699-713. doi: 10.3233/JPD-150642.
8
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.帕金森病中神经元、星形胶质细胞和少突胶质细胞α-突触核蛋白病理的神经病理学阶段。
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. doi: 10.1186/s40478-025-01944-x.
9
α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.α-突触核蛋白菌株及其与帕金森病、多系统萎缩和路易体痴呆的关系。
Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.
10
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles.脑源性和体外接种的α-突触核蛋白纤维表现出不同的生物物理特征。
Elife. 2024 Nov 25;13:RP92775. doi: 10.7554/eLife.92775.

引用本文的文献

1
Early synaptic changes and reduced brain connectivity in PD-like mice with depressive phenotype.具有抑郁表型的帕金森病样小鼠的早期突触变化及脑连接性降低
NPJ Parkinsons Dis. 2025 Aug 13;11(1):242. doi: 10.1038/s41531-025-01073-1.
2
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson's disease.帕金森病早期阶段,pSer129 α-突触核蛋白的突触富集与多巴胺能神经支配缺失相关。
Nat Commun. 2025 Jul 18;16(1):6630. doi: 10.1038/s41467-025-61052-1.
3
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.

本文引用的文献

1
In-Cell NMR Spectroscopy of Intrinsically Disordered Proteins.细胞内 NMR 光谱法研究天然无序蛋白质
Proteomics. 2019 Mar;19(6):e1800055. doi: 10.1002/pmic.201800055. Epub 2019 Jan 15.
2
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy.多系统萎缩症 iPSC 衍生多巴胺能神经元中线粒体失调和自噬受损。
Stem Cell Reports. 2018 Nov 13;11(5):1185-1198. doi: 10.1016/j.stemcr.2018.09.007. Epub 2018 Oct 18.
3
Light at the End of the Amyloid Tunnel.淀粉样蛋白隧道尽头的曙光。
帕金森病中的缺氧途径:从发病机制到治疗靶点。
Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.
4
Multivalency drives interactions of alpha-synuclein fibrils with tau.多价性驱动α-突触核蛋白纤维与 tau 的相互作用。
PLoS One. 2024 Sep 10;19(9):e0309416. doi: 10.1371/journal.pone.0309416. eCollection 2024.
5
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.区域间突触退化的差异与帕金森病和路易体痴呆症中α-突触核蛋白负担和轴突损伤有关。
Acta Neuropathol Commun. 2024 Jan 3;12(1):4. doi: 10.1186/s40478-023-01711-w.
6
The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes.雪帕假设:表型保留的无序蛋白稳定神经元和少突胶质细胞的表型。
NPJ Syst Biol Appl. 2023 Jul 11;9(1):31. doi: 10.1038/s41540-023-00291-8.
7
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?α-突触核蛋白的翻译后修饰:帕金森病治疗的潜在靶点?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.
8
Multifaceted interactions mediated by intrinsically disordered regions play key roles in alpha synuclein aggregation.由无规则区域介导的多方面相互作用在 alpha 突触核蛋白聚集过程中发挥关键作用。
Curr Opin Struct Biol. 2023 Jun;80:102579. doi: 10.1016/j.sbi.2023.102579. Epub 2023 Apr 13.
9
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features.α-突触核蛋白在5-羟色胺系统调节中的作用:生理和病理特征
Biomedicines. 2023 Feb 13;11(2):541. doi: 10.3390/biomedicines11020541.
10
Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease.在帕金森病小鼠模型中,尼古丁通过调节JNK和ERK信号通路减轻MPTP诱导的黑质纹状体损伤。
Front Pharmacol. 2023 Feb 2;14:1088957. doi: 10.3389/fphar.2023.1088957. eCollection 2023.
Biochemistry. 2018 Oct 16;57(41):5921-5922. doi: 10.1021/acs.biochem.8b00985. Epub 2018 Oct 1.
4
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.核定位和磷酸化调节α-突触核蛋白的病理作用。
Hum Mol Genet. 2019 Jan 1;28(1):31-50. doi: 10.1093/hmg/ddy326.
5
Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel.全长α-突触核蛋白的冷冻电镜解析揭示了具有共同结构核心的纤维多态性。
Nat Commun. 2018 Sep 6;9(1):3609. doi: 10.1038/s41467-018-05971-2.
6
Membrane binding, internalization, and sorting of alpha-synuclein in the cell.α-突触核蛋白在细胞中的膜结合、内化和分拣。
Acta Neuropathol Commun. 2018 Aug 14;6(1):79. doi: 10.1186/s40478-018-0578-1.
7
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
8
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.突触结合蛋白 III 缺乏症阻碍了基于 AAV 的帕金森病小鼠模型中α-突触核蛋白的聚集、纹状体突触损伤和黑质神经元丢失。
Acta Neuropathol. 2018 Oct;136(4):621-639. doi: 10.1007/s00401-018-1892-1. Epub 2018 Jul 25.
9
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.α-突触核蛋白寡聚体诱导人 iPSC 为基础的突触核蛋白病模型中的早期轴突功能障碍。
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7813-7818. doi: 10.1073/pnas.1713129115. Epub 2018 Jul 10.
10
The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson's disease.α-突触核蛋白在帕金森病发病机制中对微管稳定性的直接和间接影响。
Neuropsychiatr Dis Treat. 2018 Jun 27;14:1685-1695. doi: 10.2147/NDT.S166322. eCollection 2018.